Robert A. Ingram

Vice Chairman Pharmaceuticals
GlaxoSmithKline

View PowerPoint 

Mr. Ingram serves as Vice Chairman Pharmaceuticals at GlaxoSmithKline (plc), and previously served as the Chief Operating Officer and President of Pharmaceutical operations.  He began his career in the pharmaceutical industry as a sales representative for the company that would later become Merrell Dow Pharmaceuticals, Inc.  He advanced rapidly through sales management at Merrell Dow and into government and public affairs.  He left Merrell Dow in 1985 as Vice President of Public Affairs to become Vice President of Government Affairs at Merck & Co., Inc.  In 1988, he was promoted to President of Merck Frosst Canada, Inc.  In 1990, Mr. Ingram left Merck to join Glaxo, Inc., Glaxo plc’s U.S. subsidiary, as Executive Vice President of Administrative and Regulatory Affairs and assumed a series of increasingly responsible positions, including Group Vice President.  He was named Executive Vice President in January 1993, President and Chief Operating Officer in June 1993, President and Chief Executive Officer in March 1994 and Chairman in January 1999.  As an Executive Director of Glaxo Wellcome plc, Mr. Ingram held responsibility for operations in North America and Latin America.  He was appointed to the global company’s board in May 1995.  In October 1997, he became Chief Executive of Glaxo Wellcome with responsibility for worldwide business operations, and added the position of Chairman to his responsibilities.   

He was appointed Chairman of the Board, OSI Pharmaceuticals, Inc. effective January 1, 2003, and appointed Chairman of the Board, Valeant Pharmaceuticals International effective September 2003.  He serves on the board of directors of Allergan, Inc., Lowe’s Companies, Edwards Lifesciences Corporation, and Wachovia Corporation.   

In addition to his professional responsibilities, Mr. Ingram was asked by former U.S. President George H.W. Bush to form and chair the CEO Roundtable on Cancer.  He also currently serves as Chairman of the Board of Trustees of the American Cancer Society Foundation, and is a member of numerous other civic and professional organizations.  On July 27, 2006, he was appointed by President George W. Bush to the National Institutes of Health, National Cancer Advisory Board.  Mr. Ingram is also a frequent speaker at industry, pharmacy and government seminars. Mr. Ingram graduated from Eastern Illinois University with a B.S. degree in Business Administration.